Compound ID | 667
Saigenmycin
Class: Oxazolomycin
| Institute where first reported: | Upjohn Company (Pfizer, USA) |
| Year first mentioned: | 1986 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Weak activity on Gram positives |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.